Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victoria Rollinson

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Genes|November 17, 2020
Pharmacogenomics for Primary Care: An OverviewVictoria Rollinson, Richard Turner, Munir Pirmohamed
The Lancet. Respiratory Medicine|April 26, 2020
Screening and triage at health-care facilities in Timor-Leste during the COVID-19 pandemicRosemary Howitt, Gustodio Alves de Jesus, Flavio Araujo, et al.
Nature Medicine|August 8, 2025
Early-life serological profiles and the development of natural protective humoral immunity to Streptococcus pyogenes in a high-burden settingAlexander J Keeley, Fatoumata E Camara, Edwin P Armitage, et al.
Nature Medicine|September 24, 2025
Publisher Correction: Early-life serological profiles and the development of natural protective humoral immunity to Streptococcus pyogenes in a high-burden settingAlexander J Keeley, Fatoumata E Camara, Edwin P Armitage, et al.
Clinical Pharmacology and Therapeutics|June 24, 2025
Pharmacogenetic Implementation Studies-Lessons Learned From the PREPARE StudyHenk-Jan Guchelaar, Cathelijne H van der Wouden, Lisanne E N Manson, et al.
Lancet (London, England)|February 4, 2023
A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation studyJesse J Swen, Cathelijne H van der Wouden, Lisanne En Manson, et al.
Eclinicalmedicine|January 8, 2026
Multinational cost-utility analysis of panel-based pharmacogenetics-guided treatment of patients enrolled in the U-PGx PREPARE studyVasileios Fragoulakis, Jesse J Swen, Margarita-Ioanna Koufaki, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Genes|November 17, 2020
Pharmacogenomics for Primary Care: An OverviewVictoria Rollinson, Richard Turner, Munir Pirmohamed
The Lancet. Respiratory Medicine|April 26, 2020
Screening and triage at health-care facilities in Timor-Leste during the COVID-19 pandemicRosemary Howitt, Gustodio Alves de Jesus, Flavio Araujo, et al.
Nature Medicine|August 8, 2025
Early-life serological profiles and the development of natural protective humoral immunity to Streptococcus pyogenes in a high-burden settingAlexander J Keeley, Fatoumata E Camara, Edwin P Armitage, et al.
Nature Medicine|September 24, 2025
Publisher Correction: Early-life serological profiles and the development of natural protective humoral immunity to Streptococcus pyogenes in a high-burden settingAlexander J Keeley, Fatoumata E Camara, Edwin P Armitage, et al.
Clinical Pharmacology and Therapeutics|June 24, 2025
Pharmacogenetic Implementation Studies-Lessons Learned From the PREPARE StudyHenk-Jan Guchelaar, Cathelijne H van der Wouden, Lisanne E N Manson, et al.
Lancet (London, England)|February 4, 2023
A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation studyJesse J Swen, Cathelijne H van der Wouden, Lisanne En Manson, et al.
Eclinicalmedicine|January 8, 2026
Multinational cost-utility analysis of panel-based pharmacogenetics-guided treatment of patients enrolled in the U-PGx PREPARE studyVasileios Fragoulakis, Jesse J Swen, Margarita-Ioanna Koufaki, et al.
Pageof 1